Latest Articles

Publication Date
AstraZeneca to Withdraw Life-Saving Breast Cancer Drug from Australian Market This Year - SSBCrack

AstraZeneca to Withdraw Life-Saving Breast Cancer Drug from Australian Market This Year SSBCrack

Published: June 4, 2026, 1:03 a.m.
Initial Results of FAPI PET/MRI to Assess the Extent of Endometriosis.

Endometriosis is a common gynecologic disorder often associated with chronic pelvic pain, infertility, and reduced quality of life. Conventional imaging modalities, such as transvaginal ultrasound and MRI, may underestimate the …

Published: June 4, 2026, midnight
Deciphering the Pleiotropic Role of ARID1a and RIF1 in Endometrioid Ovarian Cancer.

Given the challenges in early detection and diagnosis, understanding the molecular underpinnings of endometrioid ovarian cancer (EOC) is crucial for improving patient outcomes. This multi-level study provides a new perspective …

Published: June 4, 2026, midnight
Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026 - Karyopharm

Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026 Karyopharm

Published: June 3, 2026, 10:53 p.m.
AUDIO: AstraZeneca pulls critical breast cancer drug from shelves - Australian Broadcasting Corporation

AUDIO: AstraZeneca pulls critical breast cancer drug from shelves Australian Broadcasting Corporation

Published: June 3, 2026, 9:59 p.m.
Life-saving breast cancer and endometriosis drug to be discontinued - Australian Broadcasting Corporation

Life-saving breast cancer and endometriosis drug to be discontinued Australian Broadcasting Corporation

Published: June 3, 2026, 6:49 p.m.
Lifesaving breast cancer and endometriosis drug to be pulled from shelves - Australian Broadcasting Corporation

Lifesaving breast cancer and endometriosis drug to be pulled from shelves Australian Broadcasting Corporation

Published: June 3, 2026, 6:49 p.m.
Life-saving breast cancer and endometriosis drug to be pulled from shelves - Australian Broadcasting Corporation

Life-saving breast cancer and endometriosis drug to be pulled from shelves Australian Broadcasting Corporation

Published: June 3, 2026, 6:49 p.m.
The same molecular group that slows colorectal cancer drives endometrial cancer in a Lleida study - apd.cat

The same molecular group that slows colorectal cancer drives endometrial cancer in a Lleida study apd.cat

Published: June 3, 2026, 3:47 p.m.
Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer - The ASCO Post

Addition of Pembrolizumab to Chemotherapy Continues to Demonstrate Overall Survival Benefit in Advanced or Recurrent Endometrial Cancer The ASCO Post

Published: June 3, 2026, 2:49 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!